Literature DB >> 17040619

Improving outcomes in difficult bone cancers using multimodality therapy, including radiation: physician and nursing perspectives.

Pete Anderson1, Maritza Salazar-Abshire.   

Abstract

Principles of therapy are similar for Ewing's sarcoma and osteosarcoma. Chemotherapy or surgery alone cures few patients. Multimodality measures are needed for durable response. Quality of life and function are very important short- and long-term considerations. The spine, sacrum, pelvis, ankle, hand, mediastinum, pulmonary hilum, and chest wall are examples of bone cancer locations for which surgery is difficult. Patients with positive margins may need radiation and may experience systemic therapy delay, recurrence, loss of function, or any combination of these. When radiation is used as a means of local control, concomitant chemotherapy can increase its effectiveness. Options for difficult Ewing's sarcoma and osteosarcoma situations and multimodality solutions, including 1 mCi/kg of samarium and proton therapy, are discussed. Combination radiation and chemotherapy regimens are summarized, and organization of patients, caregivers, and medical teams for multimodality therapy is described, along with tools used in our institution that aid in this process.

Entities:  

Mesh:

Year:  2006        PMID: 17040619     DOI: 10.1007/s11912-006-0069-6

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  49 in total

1.  Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial.

Authors:  Allen M Goorin; Michael B Harris; Mark Bernstein; William Ferguson; Meenakshi Devidas; Gene P Siegal; Mark C Gebhardt; Cindy L Schwartz; Michael Link; Holcombe E Grier
Journal:  J Clin Oncol       Date:  2002-01-15       Impact factor: 44.544

Review 2.  The role and limitations of radiofrequency ablation in treatment of bone and soft tissue tumors.

Authors:  Kamran Ahrar
Journal:  Curr Oncol Rep       Date:  2004-07       Impact factor: 5.075

Review 3.  Stressing out over survival: glutamine as an apoptotic modulator.

Authors:  Bryan C Fuchs; Barrie P Bode
Journal:  J Surg Res       Date:  2005-09-08       Impact factor: 2.192

4.  Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

Authors:  Paul A Meyers; Cindy L Schwartz; Mark Krailo; Eugenie S Kleinerman; Donna Betcher; Mark L Bernstein; Ernest Conrad; William Ferguson; Mark Gebhardt; Allen M Goorin; Michael B Harris; John Healey; Andrew Huvos; Michael Link; Joseph Montebello; Helen Nadel; Michael Nieder; Judith Sato; Gene Siegal; Michael Weiner; Robert Wells; Lester Wold; Richard Womer; Holcombe Grier
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

Review 5.  Samarium for osteoblastic bone metastases and osteosarcoma.

Authors:  Pete Anderson
Journal:  Expert Opin Pharmacother       Date:  2006-08       Impact factor: 3.889

Review 6.  Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea.

Authors:  Rohini Sharma; Peter Tobin; Stephen J Clarke
Journal:  Lancet Oncol       Date:  2005-02       Impact factor: 41.316

7.  Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era.

Authors:  Trang H La; Paul A Meyers; Leonard H Wexler; Kaled M Alektiar; John H Healey; Michael P Laquaglia; Patrick J Boland; Suzanne L Wolden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-28       Impact factor: 7.038

8.  Neoadjuvant chemotherapy and local radiotherapy for high-grade osteosarcoma of the extremities.

Authors:  Gennady N Machak; Sergey I Tkachev; Yuriy N Solovyev; Pavel A Sinyukov; Stanislav M Ivanov; Natalya V Kochergina; Alexey D Ryjkov; Valery V Tepliakov; Benjamin Y Bokhian; Valeria V Glebovskaya
Journal:  Mayo Clin Proc       Date:  2003-02       Impact factor: 7.616

9.  The patterns of relapse in osteosarcoma: the Memorial Sloan-Kettering experience.

Authors:  Susan N Chi; Laurie S Conklin; Jing Qin; Paul A Meyers; Andrew G Huvos; John H Healey; Richard Gorlick
Journal:  Pediatr Blood Cancer       Date:  2004-01       Impact factor: 3.167

Review 10.  Uncertainties in physical and biological targeting with radiation therapy.

Authors:  James D Cox; Naomi R Schechter; Andrew K Lee; Kenneth Forster; Craig W Stevens; Kie-Kian Ang; Ritsuko Komaki; Zhongxing Liao; Luka Milas
Journal:  Rays       Date:  2003 Jul-Sep
View more
  7 in total

1.  Mifamurtide in metastatic and recurrent osteosarcoma: a patient access study with pharmacokinetic, pharmacodynamic, and safety assessments.

Authors:  P M Anderson; P Meyers; E Kleinerman; K Venkatakrishnan; D P Hughes; C Herzog; W Huh; R Sutphin; Y M Vyas; V Shen; A Warwick; N Yeager; C Oliva; B Wang; Y Liu; A Chou
Journal:  Pediatr Blood Cancer       Date:  2013-08-31       Impact factor: 3.167

2.  Radium-223 dichloride therapy in breast cancer with osseous metastases.

Authors:  Amol Takalkar; Bhavna Paryani; Scott Adams; Vivek Subbiah
Journal:  BMJ Case Rep       Date:  2015-11-18

3.  Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicine.

Authors:  Vivek Subbiah; Michael J Wagner; Mary F McGuire; Nawid M Sarwari; Eswaran Devarajan; Valerae O Lewis; Shanon Westin; Shumei Kato; Robert E Brown; Pete Anderson
Journal:  Oncotarget       Date:  2015-12-01

Review 4.  Guideline and Implementation of Osteosarcoma Nursing Care for Children and Adolescents.

Authors:  Qian Gao; Yuhong Yao; Qi Xu
Journal:  Appl Bionics Biomech       Date:  2022-10-11       Impact factor: 1.664

5.  Radium-223 dichloride bone-targeted alpha particle therapy for hormone-refractory breast cancer metastatic to bone.

Authors:  Amol Takalkar; Scott Adams; Vivek Subbiah
Journal:  Exp Hematol Oncol       Date:  2014-09-08

6.  JNK pathway mediates curcumin-induced apoptosis and autophagy in osteosarcoma MG63 cells.

Authors:  Yaowu Zhang; Pingbo Chen; Hangang Hong; Lei Wang; Yubo Zhou; Yi Lang
Journal:  Exp Ther Med       Date:  2017-05-31       Impact factor: 2.447

Review 7.  Strategies to Mitigate Chemotherapy and Radiation Toxicities That Affect Eating.

Authors:  Peter M Anderson; Stefanie M Thomas; Shauna Sartoski; Jacob G Scott; Kaitlin Sobilo; Sara Bewley; Laura K Salvador; Maritza Salazar-Abshire
Journal:  Nutrients       Date:  2021-12-08       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.